According to Silk Road Medical
's latest financial reports the company has a price-to-book ratio of 5.70.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 3.16 | -74.29% |
2022-12-31 | 12.3 | -34.48% |
2021-12-31 | 18.8 | -6.48% |
2020-12-31 | 20.1 | 14.3% |
2019-12-31 | 17.6 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.7844 | -86.25% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 3.48 | -39.07% | ๐บ๐ธ USA |